External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background/Aims: The eCura system, a scoring model for stratifying the lymph node metastasis risk after noncurative endoscopic resection for early gastric cancer (EGC), has been internally validated, primarily for differentiated-type EGC. We aimed to externally validate this model for undifferentiated-type EGC. Methods: This multicenter, retrospective cohort study included 634 patients who underwent additional surgery (radical surgery group, n=270) or were followed up without additional treatment (no additional treatment group, n=364) after noncurative endoscopic resection for undifferentiated- type EGC between 2005 and 2015. The lymph node metastasis and survival rates were compared according to the risk categories. Results: For the radical surgery group, the lymph node metastasis rates were 2.6%, 10.9%, and 14.8% for the low-, intermediate-, and high-risk eCura categories, respectively (p for trend=0.003). For the low-, intermediate-, and high-risk categories in the no additional treatment group, the overall survival (92.7%, 68.9%, and 80.0% at 5 years, respectively, p<0.001) and cancer-specific survival rates (99.7%, 94.7%, and 80.0% at 5 years, respectively, p<0.001) differed significantly. In the multivariate analysis, the hazard ratios (95% confidence interval) in the no additional treatment group relative to the radical surgery group were 3.18 (1.41 to 7.17; p=0.005) for overall mortality and 2.60 (0.46 to 14.66; p=0.280) for cancer-specific mortality in the intermediate-tohigh risk category. No such differences were noted in the low-risk category. Conclusions: The eCura system can be applied to undifferentiated-type EGC. Close follow-up without additional treatment might be considered for low-risk patients, while additional surgery is recommended for intermediate- and high-risk patients.
Abstract
Background/Aims: The eCura system, a scoring model for stratifying the lymph node metastasis risk after noncurative endoscopic resection for early gastric cancer (EGC), has been internally validated, primarily for differentiated-type EGC. We aimed to externally validate this model for undifferentiated-type EGC. Methods: This multicenter, retrospective cohort study included 634 patients who underwent additional surgery (radical surgery group, n=270) or were followed up without additional treatment (no additional treatment group, n=364) after noncurative endoscopic resection for undifferentiated- type EGC between 2005 and 2015. The lymph node metastasis and survival rates were compared according to the risk categories. Results: For the radical surgery group, the lymph node metastasis rates were 2.6%, 10.9%, and 14.8% for the low-, intermediate-, and high-risk eCura categories, respectively (p for trend=0.003). For the low-, intermediate-, and high-risk categories in the no additional treatment group, the overall survival (92.7%, 68.9%, and 80.0% at 5 years, respectively, p<0.001) and cancer-specific survival rates (99.7%, 94.7%, and 80.0% at 5 years, respectively, p<0.001) differed significantly. In the multivariate analysis, the hazard ratios (95% confidence interval) in the no additional treatment group relative to the radical surgery group were 3.18 (1.41 to 7.17; p=0.005) for overall mortality and 2.60 (0.46 to 14.66; p=0.280) for cancer-specific mortality in the intermediate-tohigh risk category. No such differences were noted in the low-risk category. Conclusions: The eCura system can be applied to undifferentiated-type EGC. Close follow-up without additional treatment might be considered for low-risk patients, while additional surgery is recommended for intermediate- and high-risk patients.
참고문헌 (30)
- Guideline Committee of the Korean Gastric Cancer Association, "Korean Practice Guideline for Gastric Cancer 2018; Evidence-based, Multi-disciplinary Approach", Journal of Gastric Cancer, 19(1), pp.1~48 (2019), 대한위암학회[DOI]
- 박찬혁, "Clinical Practice Guideline for Endoscopic Resection of Early Gastrointestinal Cancer", Clinical Endoscopy, 53(2), pp.142~166 (2020), 대한소화기내시경학회[DOI]
- Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2018(5th edition)", Gastric Cancer, 24, pp.1~21 (2021)
- Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer(second edition)", Dig Endosc, 33, pp.4~20 (2021)
- "NCCN clinical practice guidelines in oncology: gastric cancer" (2021)[URL]
- Pimentel-Nunes P, "Endoscopic submucosal dissection : European Society of Gastrointestinal Endoscopy(ESGE)guideline", Endoscopy, 47, pp.829~854 (2015)
- Banks M, "British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma", Gut, 68, pp.1545~1575 (2019)
- Yang HJ, "Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer", Surg Endosc, 29, pp.1145~1155 (2015)
- Kim ER, "Effect of rescue surgery after non-curative endoscopic resection of early gastric cancer", Br J Surg, 102, pp.1394~1401 (2015)
- Hatta W, "Is radical surgery necessary in all patients who do not meet the curative criteria for endoscopic submucosal dissection in early gastric cancer? A multi-center retrospective study in Japan", J Gastroenterol, 52, pp.175~184 (2017)
- Suzuki H, "Clinical outcomes of early gastric cancer patients after noncurative endoscopic submucosal dissection in a large consecutive patient series", Gastric Cancer, 20, pp.679~689 (2017)
- Kawata N, "Risk factors for lymph node metastasis and long-term outcomes of patients with early gastric cancer after non-curative endoscopic submucosal dissection", Surg Endosc, 31, pp.1607~1616 (2017)
- Kusano C, "Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer? Long-term comparative outcomes.", Am J Gastroenterol, 106, pp.1064~1069 (2011)
- Oda I, "Treatment strategy after non-curative endoscopic resection of early gastric cancer", Br J Surg, 95, pp.1495~1500 (2008)
- Hatta W, "A scoring system to stratify curability after endoscopic submucosal dissection for early gastric cancer : "eCura system"", Am J Gastroenterol, 112, pp.874~881 (2017)
- Hatta W, "Is the eCura system useful for selecting patients who require radical surgery after noncurative endoscopic submucosal dissection for early gastric cancer? A comparative study", Gastric Cancer, 21, pp.481~489 (2018)
- Bang CS, "Endoscopic submucosal dissection for early gastric cancer with undifferentiatedtype histology : a meta-analysis", World J Gastroenterol, 21, pp.6032~6043 (2015)
- Takizawa K, "A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer : Japan Clinical Oncology Group study(JCOG1009", 1010), 2021, pp.24, 479~491
- Oka S, "Clinical validity of the expanded criteria for endoscopic resection of undifferentiated-type early gastric cancer based on long-term outcomes", Surg Endosc, 28, pp.639~647 (2014)
- Abe S, "Short-and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer", Endoscopy, 45, pp.703~707 (2013)
- Yang HJ, "Risk factors of lymph node metastasis after non-curative endoscopic resection of undifferentiated-type early gastric cancer", Gastric Cancer, 24, pp.168~178 (2021)
- Japanese Gastric Cancer Association, "Japanese classification of gastric carcinoma : 3rd English edition", Gastric Cancer, 14, pp.101~112 (2011)
- 이준행, "Clinical Practice Guidelines for Gastric Cancer in Korea: An Evidence-Based Approach", Journal of Gastric Cancer, 14(2), pp.87~104 (2014), 대한위암학회[DOI]
- 김진희, "Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era", Cancer Research and Treatment, 51(2), pp.788~796 (2019), 대한암학회
- Kang HJ, "Synergistic effect of lymphatic invasion and venous invasion on the risk of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer", J Gastrointest Surg, 24, pp.1499~1509 (2020)
- Sekiguchi M, "Risk factors for lymphatic and venous involvement in endoscopically resected gastric cancer", J Gastroenterol, 48, pp.706~712 (2013)
- Hatta W, "Prevalence and risk factors for lymph node metastasis after noncurative endoscopic resection for early gastric cancer : a systematic review and meta-analysis", J Gastroenterol, 55, pp.742~753 (2020)
- Yang HJ, "Clinical outcomes of endoscopic resection for undifferentiated intramucosal early gastric cancer larger than 2 cm", Gastric Cancer, 24, pp.435~444 (2021)
- 김영일, "Evaluation of Submucosal or Lymphovascular Invasion Detection Rates in Early Gastric Cancer Based on Pathology Section Interval", Journal of Gastric Cancer, 20(2), pp.165~175 (2020), 대한위암학회[DOI]
- "Comparison of endoscopic resection and surgery for early gastric cancer with undifferentiated histological type (ERASE-GC)"[URL]